+

WO1993006911A1 - Procede de traitement du sang - Google Patents

Procede de traitement du sang Download PDF

Info

Publication number
WO1993006911A1
WO1993006911A1 PCT/US1992/008060 US9208060W WO9306911A1 WO 1993006911 A1 WO1993006911 A1 WO 1993006911A1 US 9208060 W US9208060 W US 9208060W WO 9306911 A1 WO9306911 A1 WO 9306911A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
iodine
cross
filter
linked pvp
Prior art date
Application number
PCT/US1992/008060
Other languages
English (en)
Inventor
Edward Shanbrom
Herbert Lieberman
John J. Merianos
Original Assignee
Isp Investments Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isp Investments Inc. filed Critical Isp Investments Inc.
Publication of WO1993006911A1 publication Critical patent/WO1993006911A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances

Definitions

  • a method for treating blood compositions to inactivate pathogenic microorganisms therein comprises contacting cross-linked polyvinylpyrrolidone-iodine with blood, separating the cross-linked PVP-iodine and the cells therein from the soluble portion of the blood, and removing any residual iodine from the thus-treated soluble portion of the blood.
  • the preferred method comprises:
  • the cross-linked PVP-iodine has a particle size of about 40-150 microns.
  • the active agent for removing pathogenic microorganisms present in blood is the cross-linked complex of polyvinylpyrrolidone and iodine.
  • This complex is formed as the reaction product of cross-linked polyvinyl ⁇ pyrrolidone, which is available from International Specialty Products (ISP) , and molecular iodine.
  • ISP International Specialty Products
  • the cross-linked PVP-iodine is available from ISP as a stable, free-flowing powder which is water-insoluble.
  • the preferred cross-linked PVP-iodine product can be characterized as having about 10% available iodine and about 5% iodide in the complex.
  • a filter having a porosity equivalent to a 325 mesh screen, i.e. a porosity of 44 microns, was loaded with cross-linked PVP-iodine powder prepared according to the method of the aforementioned U.S. Patent Application, and having a particle size greater than 44 microns, to a bed depth of about 3 inches. Then a blood composition, with any microorganisms therein, was passed through the thus-loaded filter for a contact time of about 2 minutes. The filtrate thus-obtained showed less than 25 ppm of iodine therein. This treatment is effective in killing any microorganisms, including viruses, present in the blood sample.
  • the blood cells of the treated blood remained on the filter bed; these blood cells and the cross-linked PVP-iodine are washed with isotonic solution, and transferred to a second filter having a porosity greater than the particle size of the cross-linked PVP-iodine but smaller than the red and white blood cells.
  • washing with isotonic solution will separate the cross-linked PVP-iodine from the treated red and white blood cells.
  • the filtrate which has dead bacterial cells and dead viruses included therein is subjected to a second filtration to remove the dead bacterial cells present therein.
  • the treated soluble portion of the blood is purified by contacting it with cross-linked PVP to remove any residual iodine therein.
  • soluble blood is obtained which is substantially free of pathogenic microorganisms and residual iodine.
  • a preferred method for accomplishing this is to provide a purification filter loaded with cross-linked PVP, and passing the treated soluble portion of the blood through the loaded filter whereupon the PVP will complex with residual iodine therein on the filter, while the purified, treated soluble portion of the blood passes through.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Filtering Materials (AREA)

Abstract

On décrit un procédé de traitement du sang et de ses compositions permettant d'éliminer des microorganismes pathogènes présents dans celui-ci. L'invention consiste à mettre en contact avec du sang le complexe réticulé constitué de polyvinylpyrrolidone et d'iode (PVP-I2) et à séparer de la partie soluble du sang le complexe réticulé PVP-iode et les globules qu'il contient. Le procédé préféré consiste à charger le complexe réticulé constitué de polyvinylpyrrolidone et d'iode sur un filtre présentant une porosité inférieure soit à la grosseur des particules dudit complexe réticulé de PVP-iode, soit aux globules sanguins de la composition, à mettre en contact avec le sang le lit filtrant ainsi chargé afin de rendre inactifs les microorganismes qu'il contient, à faire passer la partie soluble traitée de la composition sanguine dans le filtre, à récupérer les globules sanguins ainsi traités restant sur le filtre, et à purifier la partie soluble traitée de la composition sanguine en la mettant en contact avec le complexe réticulé de PVP afin d'éliminer tout résidu d'iode s'y trouvant.
PCT/US1992/008060 1991-10-08 1992-09-21 Procede de traitement du sang WO1993006911A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77316691A 1991-10-08 1991-10-08
US773,166 1991-10-08
US83837692A 1992-02-19 1992-02-19
US838,376 1992-02-19

Publications (1)

Publication Number Publication Date
WO1993006911A1 true WO1993006911A1 (fr) 1993-04-15

Family

ID=27118714

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/008060 WO1993006911A1 (fr) 1991-10-08 1992-09-21 Procede de traitement du sang

Country Status (2)

Country Link
AU (1) AU2685892A (fr)
WO (1) WO1993006911A1 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0559856A4 (en) * 1991-09-03 1993-11-10 Edward Shanbrom Antimicrobial preservation of platelets and blood factors
EP0614368A4 (fr) * 1992-05-04 1994-04-12 Edward Shanbrom Sang de transfusion humain sans danger.
EP0605690A4 (fr) * 1992-06-29 1994-12-07 Edward Shanbrom Conservation de sang, de tissus et de fluides biologiques dans du peroxyde d'hydrogene et du povidone.
WO1995016511A1 (fr) * 1993-12-17 1995-06-22 Basf Aktiengesellschaft Filtre a lit profond pour l'extermination de micro-organismes et l'inactivation de virus, et son utilisation
US5591350A (en) * 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
WO1997048422A1 (fr) * 1996-06-21 1997-12-24 Edward Shanbrom Milieux de filtration de gel iode pour la desinfection de solutions proteinees
EP0910460A4 (fr) * 1996-06-21 1999-09-15 American Nat Red Cross Matrices iodees pour desinfecter des fluides biologiques
US6106773A (en) * 1998-09-24 2000-08-22 American National Red Cross Pathogen inactivating compositions for disinfecting biological fluids
WO2001010208A1 (fr) * 1999-08-05 2001-02-15 Hemo-Biotech, Inc. Desactivation d'agents biologiques toxiques dans des fluides biologiques tels que le sang
WO2001030402A1 (fr) * 1999-10-22 2001-05-03 Shanbrom Technologies Llc Protection des proteines labiles par desinfection a l'iode

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0797917B1 (fr) * 1992-09-16 2006-12-13 Triosyn Holding Inc. Méthode pour la desinfection de l'air par un désinfectant à base d'iode et de résine et systèmes pour la désinfection de l'air par des microoorganismes aeroportes

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017407A (en) * 1973-05-14 1977-04-12 West Laboratories, Inc. Methods for preparing solid iodine carrier mixtures and solid formulations of iodine with iodine carriers
US4312833A (en) * 1974-11-14 1982-01-26 Smith & Nephew Pharmaceuticals, Ltd. Sterilizing hydrophilic contact lenses
US4321257A (en) * 1974-07-08 1982-03-23 Johnson & Johnson Potentiated medicaments
US4997625A (en) * 1985-08-07 1991-03-05 Simon Gilbert I Chemical sterilization
US5071648A (en) * 1989-04-06 1991-12-10 Merocel Corporation Polymeric broad-spectrum antimicrobial materials
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017407A (en) * 1973-05-14 1977-04-12 West Laboratories, Inc. Methods for preparing solid iodine carrier mixtures and solid formulations of iodine with iodine carriers
US4321257A (en) * 1974-07-08 1982-03-23 Johnson & Johnson Potentiated medicaments
US4312833A (en) * 1974-11-14 1982-01-26 Smith & Nephew Pharmaceuticals, Ltd. Sterilizing hydrophilic contact lenses
US4997625A (en) * 1985-08-07 1991-03-05 Simon Gilbert I Chemical sterilization
US5071648A (en) * 1989-04-06 1991-12-10 Merocel Corporation Polymeric broad-spectrum antimicrobial materials
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0559856A4 (en) * 1991-09-03 1993-11-10 Edward Shanbrom Antimicrobial preservation of platelets and blood factors
EP0614368A4 (fr) * 1992-05-04 1994-04-12 Edward Shanbrom Sang de transfusion humain sans danger.
EP0605690A4 (fr) * 1992-06-29 1994-12-07 Edward Shanbrom Conservation de sang, de tissus et de fluides biologiques dans du peroxyde d'hydrogene et du povidone.
US6083408A (en) * 1993-12-17 2000-07-04 Basf Aktiengesellschaft And Schenk Filterbau Gmbh Depth-type filter for killing microorganisms and inactivating viruses which comprises a fibrous material and crospovidone-iodine and its use
WO1995016511A1 (fr) * 1993-12-17 1995-06-22 Basf Aktiengesellschaft Filtre a lit profond pour l'extermination de micro-organismes et l'inactivation de virus, et son utilisation
US5591350A (en) * 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
US6096216A (en) * 1994-06-09 2000-08-01 American National Red Cross Iodinated matrices for disinfecting biological fluids
EP0910460A4 (fr) * 1996-06-21 1999-09-15 American Nat Red Cross Matrices iodees pour desinfecter des fluides biologiques
WO1997048422A1 (fr) * 1996-06-21 1997-12-24 Edward Shanbrom Milieux de filtration de gel iode pour la desinfection de solutions proteinees
US6106773A (en) * 1998-09-24 2000-08-22 American National Red Cross Pathogen inactivating compositions for disinfecting biological fluids
WO2001010208A1 (fr) * 1999-08-05 2001-02-15 Hemo-Biotech, Inc. Desactivation d'agents biologiques toxiques dans des fluides biologiques tels que le sang
WO2001030402A1 (fr) * 1999-10-22 2001-05-03 Shanbrom Technologies Llc Protection des proteines labiles par desinfection a l'iode
AU778464B2 (en) * 1999-10-22 2004-12-09 Shanbrom Technologies, Llc Protection of labile proteins during iodine disinfection

Also Published As

Publication number Publication date
AU2685892A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
WO1993006911A1 (fr) Procede de traitement du sang
US6106773A (en) Pathogen inactivating compositions for disinfecting biological fluids
AU721799B2 (en) Iodinated matrices for disinfecting biological fluids
US5370869A (en) Antimicrobial preservation of platelets and blood factors
CA2264345A1 (fr) Systeme de prevention et de traitement de la septicemie
DE69203828T2 (de) Verfahren zur behandlung von produkten roter blutkörperchen zur langzeitlagerung frei von mikroorganismen.
US7517537B1 (en) Process for decontaminating a fluid
EP1044696A2 (fr) Elimination des virus du sang, du plasma ou du sérum
JPH09510650A (ja) 微生物を殺し、かつウイルスを失活化させるための深床濾過器及びその使用
US5591350A (en) Iodine disinfection method using a gaseous iodine treated porous medium
JP5080713B2 (ja) 多孔性膜処理によるウイルスの除去された血漿蛋白組成物の製造方法、ウイルスの除去された血漿蛋白組成物およびウイルス除去方法
EP0679405A1 (fr) Procédé pour séparer les virus contenus dans une solution de protéine
JP2914666B2 (ja) 精製方法
US6045787A (en) Protection of labile proteins during iodine disinfection
AU648823B2 (en) Antimicrobial preservation of plasma
JPH047084A (ja) タンニンによる廃液処理方法
JPWO2004035066A1 (ja) 血漿製剤または血清製剤、及びその製造方法
JP2002505674A (ja) 生物材料中のウイルスおよび分子病原体を除去する方法
WO1993004731A1 (fr) Traitement a l'iode-iodure de cellules sanguines rouges
JPH0751064A (ja) 液状パパインとその製造法
CA2387859C (fr) Protection des proteines labiles par desinfection a l'iode
EP0888131B1 (fr) Procede pour eliminer les agents transmissibles non conventionnels d'une solution proteique
JP3262920B2 (ja) 農薬廃液の処理方法
JPH06220061A (ja) 金属フタロシアニン化合物の精製方法
HUE025108T2 (en) Preparation and procedure for cleaning contaminated water

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载